Published in Gut on January 01, 2000
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Recent advances in coeliac disease. Gut (2006) 3.20
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Celiac disease and risk of fracture in adults--a review. Osteoporos Int (2014) 1.43
Fracture experience of patients with coeliac disease: a population based survey. Gut (2003) 1.30
Bone in celiac disease. Osteoporos Int (2008) 1.20
Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut (2004) 1.17
The gluten-free diet: safety and nutritional quality. Nutrients (2010) 1.13
Long-term follow-up of individuals with celiac disease: an evaluation of current practice guidelines. Can J Gastroenterol (2007) 1.12
Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci (2007) 1.12
Excess non-spine fractures in women over 50 years with celiac disease: a cross-sectional, questionnaire-based study. Osteoporos Int (2005) 0.95
Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World J Gastroenterol (2006) 0.95
Chronic gastritis and bone mineral density in women. Dig Dis Sci (2008) 0.93
Atypical celiac disease: from recognizing to managing. Gastroenterol Res Pract (2012) 0.93
Bone mass and mineral metabolism alterations in adult celiac disease: pathophysiology and clinical approach. Nutrients (2013) 0.88
Is fracture risk increased in patients with coeliac disease? Gut (2003) 0.85
Evaluation and management of skeletal health in celiac disease: position statement. Can J Gastroenterol (2012) 0.83
Management of inflammatory bowel disease. Postgrad Med J (2004) 0.83
The potential of digital X-ray radiogrammetry (DXR) in the assessment of osteopenia in children with chronic inflammatory bowel disease. Pediatr Radiol (2006) 0.81
Bone mineral density at diagnosis of celiac disease and after 1 year of gluten-free diet. ScientificWorldJournal (2014) 0.81
No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. World J Gastroenterol (2012) 0.80
Risk factors for osteoporosis in inflammatory bowel disease patients. World J Gastrointest Pathophysiol (2015) 0.80
Update on Bone Health in Pediatric Chronic Disease. Endocrinol Metab Clin North Am (2016) 0.79
Clinical relevance of changes in bone metabolism in inflammatory bowel disease. World J Gastroenterol (2010) 0.78
Detailed assessment of nutritional status and eating patterns in children with gastrointestinal diseases attending an outpatients clinic and contemporary healthy controls. Eur J Clin Nutr (2014) 0.78
The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis. Dig Dis Sci (2012) 0.77
Manipulating bone disease in inflammatory bowel disease patients. Ann Gastroenterol (2013) 0.76
Risk of fracture in coeliac disease. Gut (2003) 0.76
Prediction of low bone mineral density in patients with inflammatory bowel diseases. United European Gastroenterol J (2016) 0.76
Osteoporosis and liver disease: additional reasons for coeliac disease screening. Gut (2003) 0.75
Unplanned pregnancy in a woman with Crohn disease. Can Fam Physician (2012) 0.75
Role of Alendronate in Managing Osteoporosis in Celiac Disease - Illustrative Case Report. Gastroenterology Res (2011) 0.75
Are Men at High Risk for Osteoporosis Underscreened? A Quality Improvement Project. Perm J (2016) 0.75
Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study. Medicine (Baltimore) (2017) 0.75
Calcium in Gluten-Free Life: Health-Related and Nutritional Implications. Foods (2016) 0.75
Review. Gastroenterol Hepatol (N Y) (2007) 0.75
Screening of coeliac disease in undetected adults and patients diagnosed with irritable bowel syndrome in Riyadh, Saudi Arabia. Saudi J Biol Sci (2015) 0.75
Celiac disease-related osteopathy among Saudi celiac patients: Are we adherent to recommendations? Saudi J Gastroenterol (2017) 0.75
Is osteoporosis an autoimmune mediated disorder? Bone Rep (2017) 0.75
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med (1995) 10.99
Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet (1993) 9.34
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med (1997) 6.88
Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med (1995) 5.27
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med (1990) 4.10
Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med (1990) 3.76
Bone densitometry in clinical practice. BMJ (1995) 3.48
Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med (1990) 3.29
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med (1993) 2.80
Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1995) 2.58
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet (1988) 2.13
Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut (1997) 2.04
Bone mineral affection in asymptomatic adult patients with celiac disease. Am J Gastroenterol (1994) 2.04
Osteoporosis in patients with inflammatory bowel disease. Gut (1987) 1.95
Department of Health shoots itself in the hip. Why the report of the Advisory Group on Osteoporosis undermines evidence based purchasing. BMJ (1996) 1.86
Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1996) 1.81
Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet (1981) 1.81
Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med (1995) 1.80
Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J Rheumatol (1996) 1.69
Prediction of hip fracture in elderly women: a prospective study. BMJ (1990) 1.68
Bone mass and metabolism in patients with celiac disease. Gastroenterology (1995) 1.59
Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis. J Intern Med (1995) 1.57
Reduced bone density in patients with inflammatory bowel disease. Gut (1997) 1.56
Reversal of osteopenia with diet in adult coeliac disease. Gut (1996) 1.48
A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut (1995) 1.47
Osteoporosis in treated adult coeliac disease. Gut (1995) 1.43
Osteoporosis in men. Endocr Rev (1995) 1.41
Bone mineral density in adult celiac patients and the effect of gluten-free diet from childhood. Am J Gastroenterol (1990) 1.39
Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr (1993) 1.37
Bone and mineral metabolism in adult celiac disease. Am J Gastroenterol (1988) 1.35
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology (1996) 1.31
Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum (1984) 1.30
Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ (1992) 1.27
Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol (1994) 1.24
Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med (1987) 1.23
Detection of low bone mineral density by dual energy x ray absorptiometry in unsuspected suboptimally treated coeliac disease. Gut (1995) 1.20
Body composition and calcium metabolism in adult treated coeliac disease. Gut (1991) 1.18
Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol (1992) 1.17
Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut (1993) 1.17
Bone mineral density in coeliac disease. Scand J Gastroenterol (1994) 1.15
Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol (1994) 1.13
Coeliac disease and bone mineral density in adult female patients. Gut (1995) 1.10
Effect of glucocorticoids on plasma testosterone in men. Acta Endocrinol (Copenh) (1978) 1.10
Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med (1986) 1.06
Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest (1979) 1.05
Broadband ultrasound attenuation in the os calcis: relationship to bone mineral at other skeletal sites. Clin Sci (Lond) (1990) 1.04
Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut (1988) 1.03
Male gonadal function in coeliac disease: 2. Sex hormones. Gut (1983) 1.02
Mechanical properties of trabecular bone from the proximal femur: a quantitative CT study. J Comput Assist Tomogr (1990) 1.00
Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol (1995) 0.95
Bone mineral density in coeliac disease. Gut (1994) 0.95
Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis. J Rheumatol (1992) 0.94
Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology (1994) 0.92
Impaired semen quality in Crohn's disease--drugs, ill health, or undernutrition? Scand J Gastroenterol (1983) 0.90
Prevention of glucocorticoid-induced osteopenia: effect of oral 25-hydroxyvitamin D and calcium. Clin Rheumatol (1989) 0.86
A strategy for osteoporosis in gastroenterology. Eur J Gastroenterol Hepatol (1998) 0.84
Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol (1988) 0.84
Preventing glucocorticoid-induced osteoporosis. N Engl J Med (1997) 0.82
Assessment of broadband ultrasound attenuation in the os calcis in vitro. Clin Sci (Lond) (1990) 0.82
Vitamin D supplementation: a word of caution. Ann Intern Med (1997) 0.78
Corticosteroid-induced osteopenia and vitamin D metabolism. Effect of vitamin D2, calcium phosphate and sodium fluoride administration. Clin Endocrinol (Oxf) (1982) 0.78
Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis. J Rheumatol (1996) 0.77
Influence of 1 alpha-(OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double blind controlled study. Clin Endocrinol (Oxf) (1983) 0.77
Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut (2000) 3.22
Painful rib syndrome--a review of 76 cases. Gut (1993) 2.53
Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther (2006) 2.49
Patchiness and duodenal-jejunal variation of the mucosal abnormality in coeliac disease and dermatitis herpetiformis. Gut (1976) 2.40
Dietary treatment of active Crohn's disease. BMJ (1997) 2.05
Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther (2010) 2.02
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Review article: monitoring for drug side-effects in inflammatory bowel disease. Aliment Pharmacol Ther (2002) 1.79
Rectal mucosal plasma cells in inflammatory bowel disease. Gut (1983) 1.56
T-lymphocyte populations in normal and coeliac small intestinal mucosa defined by monoclonal antibodies. Gut (1986) 1.56
Coeliac disease: a cause of various associated diseases? Lancet (1975) 1.53
Peroral small-intestinal biopsy: experience with the hydraulic multiple biopsy instrument in routine clinical practice. Gut (1976) 1.37
Iron deficiency anaemia--how far to investigate? Gut (1993) 1.34
Small intestinal ulceration: diagnostic difficulties in relation to coeliac disease. Gut (1983) 1.28
Transgenic songbirds offer an opportunity to develop a genetic model for vocal learning. Proc Natl Acad Sci U S A (2009) 1.28
Salmonella gastroenteritis--another cause of erythema nodosum. Br J Dermatol (1980) 1.26
What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol (1988) 1.23
Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol (1997) 1.21
Gastro-oesophageal candidiasis. Gut (1982) 1.20
Defining duodenitis: quantitative histological study of mucosal responses and their correlations. J Clin Pathol (1985) 1.17
Small intestinal plasma cells in coeliac disease. Gut (1984) 1.16
Histocompatibility antigens in chronic liver disease. Gastroenterology (1977) 1.15
Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies. Clin Pharmacol Ther (2009) 1.14
Endoscopic small intestinal biopsy. Gastrointest Endosc (1981) 1.13
Endomysial antibody in the diagnosis and management of coeliac disease. Postgrad Med J (2000) 1.11
Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies. Infect Immun (1987) 1.11
Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock. Circ Shock (1989) 1.05
Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera to gram-negative endotoxin core glycolipids. Vox Sang (1987) 1.01
Coeliac disease and dermatitis herpetiformis: further studies of their relationship. Gut (1976) 0.99
To perform or not to perform liver biopsy: an alternative view. Gut (2003) 0.97
Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction. Gut (1991) 0.97
Jejunal mucosal immunoglobulins and complement in untreated coeliac disease. J Pathol (1977) 0.96
Successful evacuation of a pontine hematoma secondary to rupture of a pathologically diagnosed "cryptic" vascular malformation. Case report. J Neurosurg (1973) 0.96
Excess non-spine fractures in women over 50 years with celiac disease: a cross-sectional, questionnaire-based study. Osteoporos Int (2005) 0.95
Duodenal bulb plasma cells in duodenitis and duodenal ulceration. Gut (1985) 0.93
Ulcerative colitis: one disease or two? (Quantitative histological differences between distal and extensive disease). Gut (1990) 0.92
Proceedings: Patchiness of the mucosal abnormality in coeliac disease (CD) and dermatitis herpetiformis (DH). Gut (1975) 0.92
HL-As and the immune response to gluten. Lancet (1974) 0.90
Bacterial endocarditis after endoscopy. Lancet (1980) 0.90
Interpretation of serum creatine kinase in suspected myocardial infarction. Br Med J (1974) 0.90
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma. Ann Oncol (2012) 0.89
Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation. J Pathol (2000) 0.88
Coeliac disease: the cause of the various associated disorders? Eur J Gastroenterol Hepatol (2001) 0.87
The Cronkhite-Canada syndrome: an ultrastructural study of pathogenesis. J Clin Pathol (1985) 0.85
Depressed cell-mediated immunity in coeliac disease. Gut (1976) 0.85
A strategy for osteoporosis in gastroenterology. Eur J Gastroenterol Hepatol (1998) 0.84
A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J Nutr Health Aging (2013) 0.84
Vascular dynamics of an experimental cerebral arteriovenous shunt in the primate. Surg Neurol (1978) 0.84
Involvement of the small intestine in systemic mast cell disease. Gut (1975) 0.83
Jejunal mucosal gamma glutamyl transferase activity in coeliac disease. Gut (1977) 0.82
Hepatic encephalopathy. Br Med J (1973) 0.81
How effective are the usual treatments for ulcerative colitis? Aliment Pharmacol Ther (2004) 0.80
The definition and diagnosis of coeliac disease. J R Coll Physicians Lond (1977) 0.80
A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice. Aliment Pharmacol Ther (1997) 0.79
Ascites and oedema in liver disease. Br Med J (1973) 0.79
Collection and orientation of gastric and intestinal biopsies for combined light and electron microscopy. Med Lab Sci (1983) 0.79
Inflammatory bowel disease and refractory anaemia (myelodysplasia). Gut (1993) 0.78
Hypobetalipoproteinaemia--a variant of the Bassen-Kornzweig syndrome. Gut (1979) 0.78
Coeliac disease with mild mucosal abnormalities: a report of four patients. Postgrad Med J (1977) 0.78
Spinal epidural hematoma. JAMA (1976) 0.78
Letter: HL-A8 and HL-A12 in coeliac disease. Lancet (1974) 0.78
Small bowel telangiectasia in scleroderma. Ann Rheum Dis (1995) 0.78
Snow-white duodenum: a new endoscopic sign in a patient with hypobetalipoproteinemia. Gastrointest Endosc (1978) 0.77
How effective are the usual treatments for Crohn's disease? Aliment Pharmacol Ther (2004) 0.77
Analysis of V kappa genes in rheumatoid arthritis (RA) synovial B lymphocytes provides evidence for both polyclonal activation and antigen-driven selection. Clin Exp Immunol (1996) 0.77
Proceedings: Gluten antibodies (GA) in coeliac disease (CD) and dermatitis herpetiformis (DH). Gut (1976) 0.76
White cell scanning for inflammatory bowel disease: are biochemical markers useful referral criteria? Nucl Med Commun (2003) 0.76
Dietary antibodies and myocardial infarction. Lancet (1976) 0.76
Simple objective criteria for diagnosis of causes of acute diarrhoea on rectal biopsy. J Clin Pathol (1997) 0.76
Helicobacter pylori and nonulcer dyspepsia. N Engl J Med (1999) 0.75
Cell-mediated autoimmunity in coeliac disease. Clin Exp Immunol (1976) 0.75
Letter: Perforation of small intestine and slow-k. Br Med J (1975) 0.75
Local anaesthetic sprays and pneumonia after gastroscopy. Gut (1995) 0.75
Identification of hybridomas derived from mouse CD5+ B lymphocytes by fluorescent staining for cytoplasmic CD5 expression. Immunology (1994) 0.75
Blocked gastrostomy tubes. Lancet (1994) 0.75
Iron-deficiency anaemia in premenopausal women. Lancet (1999) 0.75
Herpes gestationis. Br Med J (1970) 0.75
Ruptured arteriovenous anomaly in a former woman astronaut candidate. Aviat Space Environ Med (1979) 0.75
The expression enzyme activity of biopsy tissue from the small intestine. Digestion (1977) 0.75
Proceedings: The incidence of coeliac diseases and HL-A8 in dermatitis herpetiformis. Gut (1975) 0.75
Care, carers and ergonomics. Nurs Stand Spec Suppl (1988) 0.75
Viral antibodies and chronic liver disease. Biomedicine (1976) 0.75
Diagnosing gluten intolerance. Lancet (1981) 0.75
HL-A8 and the immune response to various antigens. J Immunogenet (1976) 0.75
Histocompatibility antigens and myocardial infarction. Tissue Antigens (1976) 0.75
A rare case of recurrent post-streptococcal myalgia. Rheumatology (Oxford) (2002) 0.75
Early acute gastric dilatation following percutaneous endoscopic gastrostomy. Gastrointest Endosc (1995) 0.75
Bundle branch block. Br Med J (1970) 0.75
The initial investigation of jaundice in a district general hospital: a study of ultrasonography and hepatobiliary scintigraphy. Br J Radiol (1980) 0.75
Proceedings: The HL-A system and the immunological response to dietary antigens. Gut (1974) 0.75